Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;19(1):5-6.
doi: 10.1038/s41585-021-00534-5.

Outer membrane vesicle vaccines for Neisseria gonorrhoeae

Evgeny A Semchenko  1 , Kate L Seib  2
Affiliations
Comment

Outer membrane vesicle vaccines for Neisseria gonorrhoeae

Evgeny A Semchenko et al. Nat Rev Urol. 2022 Jan.

Abstract

Multidrug-resistant Neisseria gonorrhoeae is a global health problem, and the development of a vaccine is considered essential for the effective control of gonorrhoea. The use of outer membrane vesicle vaccines to prevent N. gonorrhoeae infection has garnered considerable interest, and a recent study using a mouse model of experimental gonococcal infections adds support for this approach.

PubMed Disclaimer

Conflict of interest statement

E.A.S. and K.L.S. hold patents relating to gonococcal vaccine antigens.

Comment on

References

    1. Gottlieb SL, et al. Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine. 2020;38:4362–4373. doi: 10.1016/j.vaccine.2020.02.073. - DOI - PMC - PubMed
    1. Edwards JL, Jennings MP, Apicella MA, Seib KL. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development. Crit. Rev. Microbiol. 2016;42:928–941. doi: 10.3109/1040841X.2015.1105782. - DOI - PMC - PubMed
    1. Unemo M, et al. Gonorrhoea. Nat. Rev. Dis. Primers. 2019;5:79. doi: 10.1038/s41572-019-0128-6. - DOI - PubMed
    1. Whelan J, Kløvstad H, Haugen IL, Holle MR, Storsaeter J. Ecologic study of meningococcal B vaccine and Neisseria gonorrhoeae infection, Norway. Emerg. Infect. Dis. 2016;22:1137–1139. doi: 10.3201/eid2206.151093. - DOI - PMC - PubMed
    1. Longtin J, et al. Possible impact of wide-scale vaccination against serogroup B Neisseria meningitidis on gonorrhea incidence rates in one region of Quebec, Canada. Open Forum Infect. Dis. 2017;4:S734–S735. doi: 10.1093/ofid/ofx180.002. - DOI

Publication types